Global Amyotrophic Lateral Sclerosis Drugs Market Size, Status and Forecast 2019-2025

1 Report Overview

• 1.1 Study Scope
• 1.2 Key Market Segments
• 1.3 Players Covered: Ranking by Amyotrophic Lateral Sclerosis Drugs Revenue
• 1.4 Market by Type
  • 1.4.1 Global Amyotrophic Lateral Sclerosis Drugs Market Size Growth Rate by Type: 2020 VS 2026
  • 1.4.2 Riluzole
  • 1.4.3 Edaravone (Radicava)
  • 1.4.4 CoQ10
  • 1.4.5 Butylphthalide
  • 1.4.6 Others
• 1.5 Market by Application
  • 1.5.1 Global Amyotrophic Lateral Sclerosis Drugs Market Share by Application: 2020 VS 2026
  • 1.5.2 Hospital Pharmacies
  • 1.5.3 Retail Pharmacies
  • 1.5.4 Online Pharmacies
• 1.6 Study Objectives
• 1.7 Years Considered

2 Global Growth Trends

• 2.1 Global Amyotrophic Lateral Sclerosis Drugs Market Perspective (2015-2026)
• 2.2 Global Amyotrophic Lateral Sclerosis Drugs Growth Trends by Regions
  • 2.2.1 Amyotrophic Lateral Sclerosis Drugs Market Size by Regions: 2015 VS 2020 VS 2026
  • 2.2.2 Amyotrophic Lateral Sclerosis Drugs Historic Market Share by Regions (2015-2020)
  • 2.2.3 Amyotrophic Lateral Sclerosis Drugs Forecasted Market Size by Regions (2021-2026)
• 2.3 Industry Trends and Growth Strategy
  • 2.3.1 Market Top Trends
  • 2.3.2 Market Drivers
  • 2.3.3 Market Challenges
  • 2.3.4 Porter’s Five Forces Analysis
  • 2.3.5 Amyotrophic Lateral Sclerosis Drugs Market Growth Strategy
  • 2.3.6 Primary Interviews with Key Amyotrophic Lateral Sclerosis Drugs Players (Opinion Leaders)

3 Competition Landscape by Key Players

• 3.1 Global Top Amyotrophic Lateral Sclerosis Drugs Players by Market Size
  • 3.1.1 Global Top Amyotrophic Lateral Sclerosis Drugs Players by Revenue (2015-2020)
  • 3.1.2 Global Amyotrophic Lateral Sclerosis Drugs Revenue Market Share by Players (2015-2020)
  • 3.1.3 Global Amyotrophic Lateral Sclerosis Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
• 3.2 Global Amyotrophic Lateral Sclerosis Drugs Market Concentration Ratio
  • 3.2.1 Global Amyotrophic Lateral Sclerosis Drugs Market Concentration Ratio (CR5 and HHI)
  • 3.2.2 Global Top 10 and Top 5 Companies by Amyotrophic Lateral Sclerosis Drugs Revenue in 2019
• 3.3 Amyotrophic Lateral Sclerosis Drugs Key Players Head office and Area Served
• 3.4 Key Players Amyotrophic Lateral Sclerosis Drugs Product Solution and Service
• 3.5 Date of Enter into Amyotrophic Lateral Sclerosis Drugs Market
• 3.6 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type (2015-2026)

• 4.1 Global Amyotrophic Lateral Sclerosis Drugs Historic Market Size by Type (2015-2020)
• 4.2 Global Amyotrophic Lateral Sclerosis Drugs Forecasted Market Size by Type (2021-2026)

5 Market Size by Application (2015-2026)

• 5.1 Global Amyotrophic Lateral Sclerosis Drugs Market Size by Application (2015-2020)
• 5.2 Global Amyotrophic Lateral Sclerosis Drugs Forecasted Market Size by Application (2021-2026)

6 North America

• 6.1 North America Amyotrophic Lateral Sclerosis Drugs Market Size (2015-2020)
• 6.2 Amyotrophic Lateral Sclerosis Drugs Key Players in North America (2019-2020)
• 6.3 North America Amyotrophic Lateral Sclerosis Drugs Market Size by Type (2015-2020)
• 6.4 North America Amyotrophic Lateral Sclerosis Drugs Market Size by Application (2015-2020)

7 Europe

• 7.1 Europe Amyotrophic Lateral Sclerosis Drugs Market Size (2015-2020)
• 7.2 Amyotrophic Lateral Sclerosis Drugs Key Players in Europe (2019-2020)
• 7.3 Europe Amyotrophic Lateral Sclerosis Drugs Market Size by Type (2015-2020)
• 7.4 Europe Amyotrophic Lateral Sclerosis Drugs Market Size by Application (2015-2020)

8 China

• 8.1 China Amyotrophic Lateral Sclerosis Drugs Market Size (2015-2020)
• 8.2 Amyotrophic Lateral Sclerosis Drugs Key Players in China (2019-2020)
• 8.3 China Amyotrophic Lateral Sclerosis Drugs Market Size by Type (2015-2020)
• 8.4 China Amyotrophic Lateral Sclerosis Drugs Market Size by Application (2015-2020)

9 Japan

• 9.1 Japan Amyotrophic Lateral Sclerosis Drugs Market Size (2015-2020)
• 9.2 Amyotrophic Lateral Sclerosis Drugs Key Players in Japan (2019-2020)
• 9.3 Japan Amyotrophic Lateral Sclerosis Drugs Market Size by Type (2015-2020)
• 9.4 Japan Amyotrophic Lateral Sclerosis Drugs Market Size by Application (2015-2020)

10 Southeast Asia

• 10.1 Southeast Asia Amyotrophic Lateral Sclerosis Drugs Market Size (2015-2020)
• 10.2 Amyotrophic Lateral Sclerosis Drugs Key Players in Southeast Asia (2019-2020)
• 10.3 Southeast Asia Amyotrophic Lateral Sclerosis Drugs Market Size by Type (2015-2020)
• 10.4 Southeast Asia Amyotrophic Lateral Sclerosis Drugs Market Size by Application (2015-2020)

11 India

• 11.1 India Amyotrophic Lateral Sclerosis Drugs Market Size (2015-2020)
• 11.2 Amyotrophic Lateral Sclerosis Drugs Key Players in India (2019-2020)
• 11.3 India Amyotrophic Lateral Sclerosis Drugs Market Size by Type (2015-2020)
• 11.4 India Amyotrophic Lateral Sclerosis Drugs Market Size by Application (2015-2020)

12 Central & South America

• 12.1 Central & South America Amyotrophic Lateral Sclerosis Drugs Market Size (2015-2020)
• 12.2 Amyotrophic Lateral Sclerosis Drugs Key Players in Central & South America (2019-2020)
• 12.3 Central & South America Amyotrophic Lateral Sclerosis Drugs Market Size by Type (2015-2020)
• 12.4 Central & South America Amyotrophic Lateral Sclerosis Drugs Market Size by Application (2015-2020)

13 Key Players Profiles

• 13.1 Sanofi
  • 13.1.1 Sanofi Company Details
  • 13.1.2 Sanofi Business Overview
  • 13.1.3 Sanofi Amyotrophic Lateral Sclerosis Drugs Introduction
  • 13.1.4 Sanofi Revenue in Amyotrophic Lateral Sclerosis Drugs Business (2015-2020))
  • 13.1.5 Sanofi Recent Development
• 13.2 Mitsubishi Tanabe Pharma
  • 13.2.1 Mitsubishi Tanabe Pharma Company Details
  • 13.2.2 Mitsubishi Tanabe Pharma Business Overview
  • 13.2.3 Mitsubishi Tanabe Pharma Amyotrophic Lateral Sclerosis Drugs Introduction
  • 13.2.4 Mitsubishi Tanabe Pharma Revenue in Amyotrophic Lateral Sclerosis Drugs Business (2015-2020)
  • 13.2.5 Mitsubishi Tanabe Pharma Recent Development
• 13.3 Mylan
  • 13.3.1 Mylan Company Details
  • 13.3.2 Mylan Business Overview
  • 13.3.3 Mylan Amyotrophic Lateral Sclerosis Drugs Introduction
  • 13.3.4 Mylan Revenue in Amyotrophic Lateral Sclerosis Drugs Business (2015-2020)
  • 13.3.5 Mylan Recent Development
• 13.4 Apotex
  • 13.4.1 Apotex Company Details
  • 13.4.2 Apotex Business Overview
  • 13.4.3 Apotex Amyotrophic Lateral Sclerosis Drugs Introduction
  • 13.4.4 Apotex Revenue in Amyotrophic Lateral Sclerosis Drugs Business (2015-2020)
  • 13.4.5 Apotex Recent Development
• 13.5 Glemark Generics
  • 13.5.1 Glemark Generics Company Details
  • 13.5.2 Glemark Generics Business Overview
  • 13.5.3 Glemark Generics Amyotrophic Lateral Sclerosis Drugs Introduction
  • 13.5.4 Glemark Generics Revenue in Amyotrophic Lateral Sclerosis Drugs Business (2015-2020)
  • 13.5.5 Glemark Generics Recent Development
• 13.6 Sun Pharma
  • 13.6.1 Sun Pharma Company Details
  • 13.6.2 Sun Pharma Business Overview
  • 13.6.3 Sun Pharma Amyotrophic Lateral Sclerosis Drugs Introduction
  • 13.6.4 Sun Pharma Revenue in Amyotrophic Lateral Sclerosis Drugs Business (2015-2020)
  • 13.6.5 Sun Pharma Recent Development
• 13.7 Covis Pharma
  • 13.7.1 Covis Pharma Company Details
  • 13.7.2 Covis Pharma Business Overview
  • 13.7.3 Covis Pharma Amyotrophic Lateral Sclerosis Drugs Introduction
  • 13.7.4 Covis Pharma Revenue in Amyotrophic Lateral Sclerosis Drugs Business (2015-2020)
  • 13.7.5 Covis Pharma Recent Development
• 13.8 Lunan Pharma
  • 13.8.1 Lunan Pharma Company Details
  • 13.8.2 Lunan Pharma Business Overview
  • 13.8.3 Lunan Pharma Amyotrophic Lateral Sclerosis Drugs Introduction
  • 13.8.4 Lunan Pharma Revenue in Amyotrophic Lateral Sclerosis Drugs Business (2015-2020)
  • 13.8.5 Lunan Pharma Recent Development
• 13.9 CSPC Pharmaceutical
  • 13.9.1 CSPC Pharmaceutical Company Details
  • 13.9.2 CSPC Pharmaceutical Business Overview
  • 13.9.3 CSPC Pharmaceutical Amyotrophic Lateral Sclerosis Drugs Introduction
  • 13.9.4 CSPC Pharmaceutical Revenue in Amyotrophic Lateral Sclerosis Drugs Business (2015-2020)
  • 13.9.5 CSPC Pharmaceutical Recent Development
• 13.10 Ascend Laboratories
  • 13.10.1 Ascend Laboratories Company Details
  • 13.10.2 Ascend Laboratories Business Overview
  • 13.10.3 Ascend Laboratories Amyotrophic Lateral Sclerosis Drugs Introduction
  • 13.10.4 Ascend Laboratories Revenue in Amyotrophic Lateral Sclerosis Drugs Business (2015-2020)
  • 13.10.5 Ascend Laboratories Recent Development
• 13.11 EISAI
  • 10.11.1 EISAI Company Details
  • 10.11.2 EISAI Business Overview
  • 10.11.3 EISAI Amyotrophic Lateral Sclerosis Drugs Introduction
  • 10.11.4 EISAI Revenue in Amyotrophic Lateral Sclerosis Drugs Business (2015-2020)
  • 10.11.5 EISAI Recent Development

14 Analyst's Viewpoints/Conclusions

15 Appendix

• 15.1 Research Methodology
  • 15.1.1 Methodology/Research Approach
  • 15.1.2 Data Source
• 15.2 Disclaimer